-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2024.
- Arrowhead Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$10.6M, a 1505% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$11.4M, a 664% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was -$11.4M, a 664% decline from 2023.
- Arrowhead Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.49M, a 126% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $5.8M, a 29.2% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)